Back to Search
STEPHEN COATS, DO
DO
Surgery Physician
NPI: 1487691853Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
31596(MO)
Research & Publications (20)
The effect of exemplar activation on mental representations of the ingroup: the moderating role of relative ingroup size.
PMID 17650919·Am J Psychol·2007
8-other
The structurally similar, penta-acylated lipopolysaccharides of Porphyromonas gingivalis and Bacteroides elicit strikingly different innate immune responses.
PMID 19460428·Microb Pathog·2009
4-observational
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.
PMID 19596885·Antimicrob Agents Chemother·2009
8-other
Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.
PMID 19375913·Bioorg Med Chem Lett·2009
7-preclinical
Severe keratin 5 and 14 mutations induce down-regulation of junction proteins in keratinocytes.
PMID 19616543·Exp Cell Res·2009
8-other
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib.
PMID 19671750·Mol Cancer Ther·2009
8-other
Synthesis, antiviral activity, and stability of nucleoside analogs containing tricyclic bases.
PMID 19433343·Eur J Med Chem·2009
7-preclinical
TGF-beta1 Inhibits TLR-mediated odontoblast responses to oral bacteria.
PMID 19407153·J Dent Res·2009
4-observational
Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities.
PMID 19552698·Cell Microbiol·2009
8-other
Preclinical efficacy and safety models for mAbs: the challenge of developing effective model systems.
PMID 19204884·IDrugs·2009
6-review
Approaches for the development of antiviral compounds: the case of hepatitis C virus.
PMID 19048196·Handb Exp Pharmacol·2009
6-review
Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.
PMID 19484140·Neoplasia·2009
7-preclinical
A participatory evaluation project to measure SANE nursing practice and adult sexual assault patients' psychological well-being.
PMID 18387006·J Forensic Nurs·2008
6-review
Treponema denticola does not induce production of common innate immune mediators from primary gingival epithelial cells.
PMID 18954353·Oral Microbiol Immunol·2008
8-other
Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome.
PMID 18324336·J Clin Invest·2008
8-other
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
PMID 19010911·Cancer Res·2008
7-preclinical
Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct.
PMID 17440108·Cancer Res·2007
7-preclinical
Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site.
PMID 17217428·Cell Microbiol·2007
7-preclinical
Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder?
PMID 17554363·J Invest Dermatol·2007
8-other
Hierarchical gene expression profiles of HUVEC stimulated by different lipid A structures obtained from Porphyromonas gingivalis and Escherichia coli.
PMID 17166236·Cell Microbiol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1115 ALASKA, SUITE 214
WEST PLAINS, MO 65775 - Phone
- (417) 256-9129
Quick Facts
- NPI
- 1487691853
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile